Targeting the Wnt/β-catenin signaling pathway in cancer

Y Zhang, X Wang - Journal of hematology & oncology, 2020 - Springer
The aberrant Wnt/β-catenin signaling pathway facilitates cancer stem cell renewal, cell
proliferation and differentiation, thus exerting crucial roles in tumorigenesis and therapy …

The role of hypoxia in the tumor microenvironment and development of cancer stem cell: a novel approach to developing treatment

A Emami Nejad, S Najafgholian, A Rostami… - Cancer Cell …, 2021 - Springer
Hypoxia is a common feature of solid tumors, and develops because of the rapid growth of
the tumor that outstrips the oxygen supply, and impaired blood flow due to the formation of …

Emerging agents that target signaling pathways in cancer stem cells

Y Yang, X Li, T Wang, Q Guo, T Xi, L Zheng - Journal of hematology & …, 2020 - Springer
Cancer stem cells (CSCs) contribute to the initiation, recurrence, and metastasis of cancer;
however, there are still no drugs targeting CSCs in clinical application. There are several …

A survey of current trends in computational drug repositioning

J Li, S Zheng, B Chen, AJ Butte… - Briefings in …, 2016 - academic.oup.com
Computational drug repositioning or repurposing is a promising and efficient tool for
discovering new uses from existing drugs and holds the great potential for precision …

Repurposing of drugs: An attractive pharmacological strategy for cancer therapeutics

A Kirtonia, K Gala, SG Fernandes, G Pandya… - Seminars in cancer …, 2021 - Elsevier
Human malignancies are one of the major health-related issues though out the world and
anticipated to rise in the future. The development of novel drugs/agents requires a huge …

A review of connectivity map and computational approaches in pharmacogenomics

A Musa, LS Ghoraie, SD Zhang, G Glazko… - Briefings in …, 2018 - academic.oup.com
Large-scale perturbation databases, such as Connectivity Map (CMap) or Library of
Integrated Network-based Cellular Signatures (LINCS), provide enormous opportunities for …

[HTML][HTML] Giving drugs a second chance: overcoming regulatory and financial hurdles in repurposing approved drugs as cancer therapeutics

JJ Hernandez, M Pryszlak, L Smith, C Yanchus… - Frontiers in …, 2017 - frontiersin.org
The repositioning or “repurposing” of existing therapies for alternative disease indications is
an attractive approach that can save significant investments of time and money during drug …

[PDF][PDF] Inhibition of dopamine receptor D4 impedes autophagic flux, proliferation, and survival of glioblastoma stem cells

S Dolma, HJ Selvadurai, X Lan, L Lee, M Kushida… - Cancer cell, 2016 - cell.com
Glioblastomas (GBM) grow in a rich neurochemical milieu, but the impact of neurochemicals
on GBM growth is largely unexplored. We interrogated 680 neurochemical compounds in …

Lung cancer biomarkers: present status and future developments

PT Cagle, TC Allen, RJ Olsen - Archives of Pathology …, 2013 - meridian.allenpress.com
The publication of the “Molecular Testing Guideline for Selection of Lung Cancer Patients for
EGFR and ALK Tyrosine Kinase Inhibitors: Guideline From the College of American …

A literature-based knowledge graph embedding method for identifying drug repurposing opportunities in rare diseases

DN Sosa, A Derry, M Guo, E Wei, C Brinton… - Pacific Symposium on …, 2019 - World Scientific
Millions of Americans are affected by rare diseases, many of which have poor survival rates.
However, the small market size of individual rare diseases, combined with the time and …